Journal of Clinical & Experimental Dermatology Research

Journal of Clinical & Experimental Dermatology Research
Open Access

ISSN: 2155-9554

+44 1478 350008

Case Report - (2012) Volume 3, Issue 2

Immune Reconstitution Inflammatory Syndrome: Cutaneous and Bone Histoplasmosis Mimicking Leprosy after Treatment

Samson Kimaiyo Kiprono1*, John Elisante Masenga1, Rune Nathaniel Philemon2, Baraka Michael Chaula1 and Bernard Naafs1,3
1Department of Dermatology, Regional Dermatology Training Centre, Moshi, Tanzania
2Department of Pediatrics, Tumaini University, Moshi, Tanzania
3Stichting Tropendermatologie, Munnekeburen, The Netherlands
*Corresponding Author: Samson Kimaiyo Kiprono, Regional Dermatology Training Center, Box 8332 Moshi, Tanzania, Tel: +254 722 521 673 Email:

Abstract

We present a case of disseminated histoplasmosis in a 12-year-old HIV infected boy. This is a rare presentation of Histoplasma capsulatum var. capsulatum which presented as Immune Reconstitution Inflammatory Syndrome with osteoarticular involvement. He was treated with fluconazole for five years and healed with shortening of all the digits.

<

Keywords: Cutaneous histoplasmosis; Immune reconstitution inflammatory syndrome; Bone

Introduction

Histoplasmosis is caused by Histoplasma capsulatum. It is a mycosis endemic to certain areas of America, Africa and Asia [1]. Histoplasma capsulatum var duboisii is the species that causes African histoplasmosis, which is endemic in sub-Saharan Africa. It is estimated that 95% of Histoplasma capsulatum infections are asymptomatic [2] and those that are symptomatic present with non-specific clinical features [2]. Histoplasma capsulatum has emerged as an important opportunistic infection among Human Immunodeficiency Virus (HIV) infected patients in endemic areas. Wheat et al. [3] reported that, there was a rising incidence of disseminated histoplasmosis among AIDS patients in endemic areas after a 5-year follow-up.

Case Report

A 12-year- old boy was previously treated in another hospital for persistent spiking fever and cough for one month. He had slightly painful swollen joints and hyperpigmented nodules on the face and on the lower limbs. He was treated for pulmonary tuberculosis and juvenile rheumatoid arthritis without any improvement and was referred to our hospital. He presented with persistent fever, chills, and headache. An Enzyme Linked Immunoassay test for HIV was positive with a CD4 count of 3/mm3. He was started on stavudine, lamivudine and efavirenz and continued with anti-tuberculosis treatment. After six weeks, he was re-admitted with persistent fever of 39°C and severe wasting. The joint swelling and pain had worsened bilaterally especially on the wrists and the proximal and distal inter-phalangeal joints. The skin lesions had also worsened with widespread involvement of the face extending to the scalp. The trunk, the lower and the upper limbs were also affected. Morphologically, the lesions were elevated, umbilicated nodules and hyperpigmented plaques on the back and the right leg. There were no respiratory symptoms and chest X-ray was normal. The full blood picture showed Hemoglobin 12.7 g/dl, Platelets 376,000/mm3, leucocytes 3780/mm3. The liver and the kidney function tests were within normal ranges. Blood slide for malarial parasites was negative, X-ray of the hands and the elbows showed soft tissue swelling, shortening and broadening of the digits with osteolytic changes involving metaphysis and epiphysis of the phalanges and the distal radius and ulna (Figure 1). Coarse trabeculations were also noted in the carpal bones. X-ray of the elbow showed severe narrowing of the joint space with periarticular lytic changes.

clinical-experimental-dermatology-osteolytic-lesions

Figure 1: X-ray of the hands showing osteolytic lesions and destruction of epiphyseal plates.

A biopsy of the skin lesions showed diffuse infiltrate mainly of macrophages, few polymorphs and presence of small, round basophilic cytoplasmic organelles with surrounding halo (Figure 2) which was highlighted by methenamine silver stain (Figure 3) diagnostic of Histoplasma capsulatum var. capsulatum. The CD4 count increased to 484/mm3 within three months. The final diagnosis was a Disseminated Histoplasmosis presenting as an Immune Reconstitution Inflammatory Syndrome (IRIS).

clinical-experimental-dermatology-skin-biopsy

Figure 2: Hematoxylin and eosin stain (X20) of skin biopsy showing suppurative granulomatous infiltrate with intra-cytoplasmic basophilic granules with surrounding halo without Giant cells.

clinical-experimental-dermatology-intra-cytoplasmic

Figure 3: Skin biopsy showing the intra-cytoplasmic granules staining positive with methenamine silver stain (X40).

He was started on Itraconazole (100 mg daily), while continuing with antiretroviral therapy. A rapid response was noted within one month with reduced fever, reduction of skin lesions and joint swelling and minimal pain. After six weeks his treatment was stopped by his family and he reappeared at the clinic after two months with worsening of the skin lesions and increased joint swelling. Fluconazole (200 mg daily) was commenced with good clinical improvement.

A follow-up over 5 years showed a stable CD4 above 600/mm3, softening of nodules (Figure 4) and depression of the skin lesions with anetoderma-like features, shortening of all the digits (Figures 5, 6) and deformity of the elbows joints.

clinical-experimental-dermatology-soft-nodular-lesions

Figure 4: Umblicated soft nodular lesions on the chin of the 18years boy after 6years of Fluconazole treatment.

clinical-experimental-dermatology-thicker-fingers

Figure 5: Soft, shorter and thicker fingers without loss of sensation after treatment for Histoplasmosis.

clinical-experimental-dermatology-Shortening-toes

Figure 6: Shortening of the toes which is more pronounced on the big toes after treatment for Histoplasmosis.

An X-ray of the hands showed widening and shortening of the bones, normal joint spaces and no osteolytic lesions. Biopsy of the anetoderma-like lesions showed no active infiltration and the culture was negative. Fluconazole was stopped and no clinical features of relapse were noticed at six months follow-up.

Discussion

Histoplasma capsulatum is a dimorphic fungus that usually parasitizes the reticuloendothelial system, thereby involving many organs such as the spleen, the kidney, the central nervous system (CNS) and the skin [3]. Histoplasmosis is mainly acquired through inhalation whereby the lungs are frequently affected. Most individuals with histoplasmosis are asymptomatic. Those who develop clinical manifestations are usually immunocompromised or were exposed to an unusually large inoculum. Histoplasma infection may remain latent, but further dissemination may occur with impaired cell-mediated immunity. Clinically histoplasmosis is subdivided into five forms; acute pulmonary, acute disseminated, chronic pulmonary, chronic disseminated and primary cutaneous [4].

Chronic disseminated histoplasmosis caused by Histoplasma capsulatum var. capsulatum is the most common type among AIDS patients. The disseminated form presents with constitutional symptoms, which include fever, cough, weight loss, malaise, and dyspnea [3]. A highly variable presentation is noted due to the multiple organ involvement.

Among patients with chronic disseminated histoplasmosis, cutaneous lesions are relatively rare and if they are present they indicate a severely disseminated disease. It was estimated that only 6% of the patients with disseminated histoplasmosis will have cutaneous involvement [3-5]. The clinical presentation of the cutaneous histoplasmosis is highly variable and there are no pathognomic features of this disease. The clinical manifestations usually include nodules, papules, and ulcerations.

This patient’s disease is peculiar because of the joint and the bone involvement. There are only a few case reports of histoplasmosis involving the joints reported in English literature [6-8]. Simon et al. [9] reported a case of African histoplasmosis caused by Histoplasma capsulatum var. duboisii with multiple osteoarticular lesions and lymphadenopathy in an immunocompetent African patient. Bone histoplasmosis presents with destructive lesions observed in X-ray [10], which clinically resemble rheumatoid arthritis. Histoplasma capsulatum var. duboisii infections usually settle in the metaphyses of the long bones, the small bones of the hand and the flat bones. The earliest lesion is a small lytic area, which may resemble lesions of multiple myeloma or skeletal metastases. Similar osteoarticular features was seen in this case, however this was Histoplasma capsulatum var. capsulatum. To our knowledge, this is the first case of Histoplasma capsulatum var. capsulatum described with multiple bone and joint involvement resulting in an early closure of the epiphyseal plates and therefore, shortening of the digits due to impaired growth. Despite an extensive disease, the chest X-ray was normal, a feature which has been observed in 40-50% of the disseminated histoplasmosis infection in immunocompromised patients [11].

Successful treatment of HIV-infected patients with antiretroviral therapy can induce the IRIS [12]. Two different pathogenic mechanisms explain the occurrence of IRIS. These are paradoxical reaction to antigens of microbiologically inactive infectious agents despite effective anti-infectious therapy and unmasking of an active infection [13]. Nacher et al. [14] reported that patients taking Highly Active Antiretroviral Therapy (HAART) were likely to develop disseminated histoplasmosis than untreated patients. This suggests that immune reconstitution after HAART reveals undiagnosed latent disseminated histoplasmosis. The exacerbation of skin and joint symptoms after starting HAART may be due to exaggerated cell- medicated response identical to a pattern commonly seen in type 1 lepra reaction giving rise to swelling of the skin and a reactive arthritis.

Ampotericin B and ltraconazole are the antifungal agents that were noted to be effective in the treatment of histoplasmosis [15]. The availability and the cost of these medications are limiting factors in resource limited settings. This patient was treated successfully with fluconazole after a relapse with itraconazole interruption. Fluconazole was used because its availability and affordability. However, reports indicate that a high proportion of patients failed fluconazole therapy than those treated with itraconazole [16]. Flucaonazole was found to induce resistance during therapy [16]. There was no relapse after stopping maintenance treatment after the rise of the CD4 count to more than 500/mm3. Treatment should be continued until clinical and laboratory findings are normal. However 10-15% of patients will experience relapse [17]. Longer therapy and probably a lifelong suppressive therapy were proposed in patients whose immunosuppression cannot be reversed [15]. The minimum required CD4 count reconstitution to stop maintenance therapy in disseminated disease involving the bone needs further research.

The aftermath of disseminated histoplasmosis on digits resemble leprosy, but without the loss of sensation. The stigmata associated with leprosy in endemic areas are compounded by stigma associated with HIV infection and therefore, this patient requires continuous counseling.

References

  1. Fischer GB, Mocelin H, Severo CB, Oliveira Fde M, Xavier MO, et al. (2009) Histoplasmosis in children. Paediatr Respir Rev 10: 172-177.
  2. Pervez MM, Cobb B, Matin N, Shahrin L, Ford ER, et al. (2010) Disseminated histoplasmosis in a Patient with advanced HIV disease-lessons learnt from Bangladesh. J Health Popul Nutr 28: 305-307.
  3. Wheat LJ, Kauffman CA (2003) Histoplasmosis. Infect Dis Clin North Am 17: 1-19.
  4. Verma SB (2006) Chronic disseminated cutaneous histoplasmosis in an immunocompetent individual--a case report. Int J Dermatol 45: 573-576.
  5. Kauffman CA (2007) Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev 20: 115-132.
  6. Omer GE, Lockwood RS, Travis LO (1963) Histoplasmosis involving the Carpal Joint. A Case Report. J Bone Joint Surg 45: 1699-1703.
  7. Care SB, Lacey SH (1998) Recurrent histoplasmosis of the wrist: a case report. J Hand Surg Am 23: 1112-1114.
  8. Darouiche RO, Cadle RM, Zenon GJ, Weinert MF, Hamill RJ, et al. (1992) Articular histoplasmosis. J Rheumatol 19: 1991-1993.
  9. Simon F, Chouc PY, Hervé V, Branquet D, Jeandel P (1994) Bone and joint sites of African histoplasmosis (Histoplasma duboisii). Apropos of a case and review of the literature. Rev Rhum Ed Fr 61: 829-838.
  10. Schasfoort RA, Marck KW, Houtman PM (1999) Histoplasmosis of the Wrist. J Hand Surg Br 24: 625-627.
  11. Ketai L, Jordan K, Marom EM (2008) Imaging Infection. Clin Chest Med 29: 77-105.
  12. Breton G, Adle-Biassette H, Therby A, Ramanoelina J, Choudat L, et al. (2006) Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS 20: 119-121.
  13. French MA, Price P, Stone SF (2004) Immune restoration disease after antiretroviral therapy. AIDS 18: 1615-1627.
  14. Nacher M, Sarazin F, El Guedj M, Vaz T, Alvarez F, et al. (2006) Increased Incidence of Disseminated Histoplasmosis Following Highly Active Antiretroviral Therapy Initiation. J Acquir Immune Defic Syndr 41: 468-470.
  15. Wheat LJ, Freifeld AG, Kleiman MB, Baddley JW, McKinsey DS et al (2007) Clinical practice guidelines for the management of patients with histoplasmosis: 2007 Update by the Infectious Disease Society of America. Clin Inf Dis 45: 807-825.
  16. Wheat LJ, Connolly P, Smedema M, Brizendine E, Hafner R (2001) Emergence of resistance to Fluconazole as a cause of failure during treatment of Histoplasmosis in patients with Acquired Immunodeficiency Disease Syndrome. Clin Infect Dis 33: 1910-1930.
  17. Wheat J, Hafner R, Korzun AH, Limjoco MT, Spencer P, et al. (1995) Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group. Am J Med 98: 336-342.
Citation: Kiprono SK, Masenga JE, Philemon RN, Chaula BM, Naafs B (2012) Immune Reconstitution Inflammatory Syndrome: Cutaneous and Bone Histoplasmosis Mimicking Leprosy after Treatment. J Clin Exp Dermatol Res 3:145.

Copyright: © 2012 Kiprono SK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top
https://www.olimpbase.org/1937/